Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
270M
-
Shares change
-
+8.67M
-
Total reported value, excl. options
-
$2.17B
-
Value change
-
+$42.1M
-
Put/Call ratio
-
0.28
-
Number of buys
-
114
-
Number of sells
-
-85
-
Price
-
$8.02
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q3 2019
252 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q3 2019.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 270M shares
of 309M outstanding shares and own 87.47% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (24.6M shares), VANGUARD GROUP INC (23.3M shares), Redmile Group, LLC (22.8M shares), BlackRock Inc. (20.7M shares), STATE STREET CORP (11.6M shares), Avoro Capital Advisors LLC (11.1M shares), JANUS HENDERSON GROUP PLC (10.9M shares), MORGAN STANLEY (10.3M shares), WELLINGTON MANAGEMENT GROUP LLP (7.75M shares), and JENNISON ASSOCIATES LLC (7.2M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.